GDRX Valuation

GoodRx Holdings Inc

Add to Watchlist

Advanced Chart

4.350

-0.01(-0.229%)1D

Overview
Forecast
Valuation
Earnings

GDRX Relative Valuation

GDRX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, GDRX is overvalued; if below, it's undervalued.

Historical Valuation

GoodRx Holdings Inc (GDRX) is now in the Undervalued zone, suggesting that its current forward PS ratio of 1.94 is considered Undervalued compared with the five-year average of 110.00. The fair price of GoodRx Holdings Inc (GDRX) is between 4.71 to 6.41 according to relative valuation methord. Compared to the current price of 4.36 USD , GoodRx Holdings Inc is Undervalued By 7.49%.

Relative Value

Fair Zone

4.71-6.41

Current Price：4.36

7.49%

Undervalued

27.36

Trailing

Forward

6.56

EV/EBITDA

GoodRx Holdings Inc. (GDRX) has a current EV/EBITDA of 6.56. The 5-year average EV/EBITDA is 26.32. The thresholds are as follows: Strongly Undervalued below -25.04, Undervalued between -25.04 and 0.64, Fairly Valued between 52.00 and 0.64, Overvalued between 52.00 and 77.68, and Strongly Overvalued above 77.68. The current Forward EV/EBITDA of 6.56 falls within the Historic Trend Line -Fairly Valued range.

8.62

EV/EBIT

GoodRx Holdings Inc. (GDRX) has a current EV/EBIT of 8.62. The 5-year average EV/EBIT is 30.58. The thresholds are as follows: Strongly Undervalued below -27.77, Undervalued between -27.77 and 1.41, Fairly Valued between 59.76 and 1.41, Overvalued between 59.76 and 88.93, and Strongly Overvalued above 88.93. The current Forward EV/EBIT of 8.62 falls within the Historic Trend Line -Fairly Valued range.

1.88

GoodRx Holdings Inc. (GDRX) has a current PS of 1.88. The 5-year average PS is 7.97. The thresholds are as follows: Strongly Undervalued below -8.16, Undervalued between -8.16 and -0.09, Fairly Valued between 16.04 and -0.09, Overvalued between 16.04 and 24.11, and Strongly Overvalued above 24.11. The current Forward PS of 1.88 falls within the Historic Trend Line -Fairly Valued range.

7.30

P/OCF

GoodRx Holdings Inc. (GDRX) has a current P/OCF of 7.30. The 5-year average P/OCF is 15.55. The thresholds are as follows: Strongly Undervalued below -115.97, Undervalued between -115.97 and -50.21, Fairly Valued between 81.32 and -50.21, Overvalued between 81.32 and 147.08, and Strongly Overvalued above 147.08. The current Forward P/OCF of 7.30 falls within the Historic Trend Line -Fairly Valued range.

9.08

P/FCF

GoodRx Holdings Inc. (GDRX) has a current P/FCF of 9.08. The 5-year average P/FCF is 37.76. The thresholds are as follows: Strongly Undervalued below -45.60, Undervalued between -45.60 and -3.92, Fairly Valued between 79.44 and -3.92, Overvalued between 79.44 and 121.12, and Strongly Overvalued above 121.12. The current Forward P/FCF of 9.08 falls within the Historic Trend Line -Fairly Valued range.

GoodRx Holdings Inc (GDRX) has a current Price-to-Book (P/B) ratio of 2.36. Compared to its 3-year average P/B ratio of 3.01 , the current P/B ratio is approximately -21.45% higher. Relative to its 5-year average P/B ratio of 8.06, the current P/B ratio is about -70.66% higher. GoodRx Holdings Inc (GDRX) has a Forward Free Cash Flow (FCF) yield of approximately 12.12%. Compared to its 3-year average FCF yield of 7.02%, the current FCF yield is approximately 72.54% lower. Relative to its 5-year average FCF yield of 4.99% , the current FCF yield is about 143.03% lower.

2.36

P/B

Median3y

3.01

Median5y

8.06

12.51

FCF Yield

Median3y

7.02

Median5y

4.99

Competitors Valuation Multiple

The average P/S ratio for GDRX's competitors is 2.45, providing a benchmark for relative valuation. GoodRx Holdings Inc Corp (GDRX) exhibits a P/S ratio of 1.88, which is -23.22% above the industry average. Given its robust revenue growth of 1.23%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of GDRX decreased by 44.94% over the past 1 year. The primary factor behind the change was an increase in Margin Expansion from 3.34 to 6.32.

The secondary factor is the Revenue Growth, contributed 1.23%to the performance.

Overall, the performance of GDRX in the past 1 year is driven by Margin Expansion. Which is more sustainable.

1.23%

200.61M → 203.07M

Revenue Growth

89.22%

3.34 → 6.32

Margin Expansion

-135.39%

-137.81 → 48.77

P/E Change

-44.94%